BioXcel planning pivotal trial of BXCL501 for Alzheimer's agitation
BioXcel plans to test BXCL501 for treating agitation in Alzheimer’s disease dementia in patients in nursing and assisted living facilities.| Alzheimer's News Today
BioXcel plans to test BXCL501 for treating agitation in Alzheimer’s disease dementia in patients in nursing and assisted living facilities.| Alzheimer's News Today
Biogen is discontinuing development and commercialization of its controversial Alzheimer's treatment Aduhelm to focus its efforts on Leqembi.| Alzheimer's News Today
Amylyx Pharmaceuticals' oral therapy candidate AMX0035 improves levels of several biomarkers associated with Alzheimer's, per a new analysis.| Alzheimer's News Today
Being a sole caregiver for a loved one with Alzheimer's is hard work, says columnist Ray Burow, but help and resources are available.| Alzheimer's News Today
Taking on caregiving for a loved one with Alzheimer's can seem impossible, says columnist Ray Burow, but only until it's done.| Alzheimer's News Today
Margarida Maia is a science writer for Alzheimer's News Today with a PhD in biomedical sciences. She covers the latest news and information on a variety of Alzheimer's topics.| Alzheimer's News Today
After her father passed away, columnist Ray Burow had to help her mother, who had Alzheimer's, process her emotions and grief.| Alzheimer's News Today
Experimental blarcamesine (Anavex 2-73) was able to slow cognitive and functional decline in early Alzheimer’s patients over a year, data show.| Alzheimer's News Today
Columnist Ray Burow, reflecting on caregiving for her late mother, ponders if it's sometimes OK to lie to a person with Alzheimer's disease.| Alzheimer's News Today
Category archive page for News.| Alzheimer's News Today
Columnist Ray Burow can attest to the challenges that sandwich generation caregivers face, but says her children learned valuable lessons.| Alzheimer's News Today
